136 related articles for article (PubMed ID: 38896263)
1. Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.
Krieger B; Schneider-Gold C; Genç E; Güntürkün O; Prehn C; Bellenberg B; Lukas C
J Neurol; 2024 Jun; ():. PubMed ID: 38896263
[TBL] [Abstract][Full Text] [Related]
2. Differences in diffusion tensor imaging parameters of brain white matter tracts between patients with myotonic dystrophy type 1 and type 2 - a retrospective single-centre study.
Maj E; Wolak T; de Meulder J; Janiszewska K; Wojtaszek M; Kostera-Pruszczyk A; Gołębiowski M; Łusakowska A
Neurol Neurochir Pol; 2023; 57(5):430-437. PubMed ID: 37706668
[TBL] [Abstract][Full Text] [Related]
3. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
[TBL] [Abstract][Full Text] [Related]
4. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
Schneider-Gold C; Bellenberg B; Prehn C; Krogias C; Schneider R; Klein J; Gold R; Lukas C
PLoS One; 2015; 10(6):e0130352. PubMed ID: 26114298
[TBL] [Abstract][Full Text] [Related]
5. Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1.
Zanigni S; Evangelisti S; Giannoccaro MP; Oppi F; Poda R; Giorgio A; Testa C; Manners DN; Avoni P; Gramegna LL; De Stefano N; Lodi R; Tonon C; Liguori R
Neuroimage Clin; 2016; 11():678-685. PubMed ID: 27330968
[TBL] [Abstract][Full Text] [Related]
6. Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.
Romeo V; Pegoraro E; Ferrati C; Squarzanti F; Sorarù G; Palmieri A; Zucchetta P; Antunovic L; Bonifazi E; Novelli G; Trevisan CP; Ermani M; Manara R; Angelini C
J Neurol; 2010 Aug; 257(8):1246-55. PubMed ID: 20221771
[TBL] [Abstract][Full Text] [Related]
7. White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study.
Labayru G; Camino B; Jimenez-Marin A; Garmendia J; Villanua J; Zulaica M; Cortes JM; López de Munain A; Sistiaga A
Sci Rep; 2022 Mar; 12(1):3988. PubMed ID: 35256728
[TBL] [Abstract][Full Text] [Related]
8. Brain Involvement in Myotonic Dystrophy Type 1: A Morphometric and Diffusion Tensor Imaging Study with Neuropsychological Correlation.
Cabada T; Iridoy M; Jericó I; Lecumberri P; Seijas R; Gargallo A; Gomez M
Arch Clin Neuropsychol; 2017 Jun; 32(4):401-412. PubMed ID: 28164212
[TBL] [Abstract][Full Text] [Related]
9. Structural white matter networks in myotonic dystrophy type 1.
van Dorst M; Okkersen K; Kessels RPC; Meijer FJA; Monckton DG; van Engelen BGM; Tuladhar AM; Raaphorst J;
Neuroimage Clin; 2019; 21():101615. PubMed ID: 30522973
[TBL] [Abstract][Full Text] [Related]
10. Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.
Gliem C; Minnerop M; Roeske S; Gärtner H; Schoene-Bake JC; Adler S; Witt JA; Hoffstaedter F; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Amunts K; Klockgether T; Weber B; Kornblum C
PLoS One; 2019; 14(3):e0213381. PubMed ID: 30845252
[TBL] [Abstract][Full Text] [Related]
11. Cortical Thickness and White Matter Integrity are Associated with CTG Expansion Size in Myotonic Dystrophy Type I.
Yoo WK; Park YG; Choi YC; Kim SM
Yonsei Med J; 2017 Jul; 58(4):807-815. PubMed ID: 28540995
[TBL] [Abstract][Full Text] [Related]
12. Learning Spectral Fractional Anisotropy and Mean Diffusivity Features as Neuroimaging Biomarkers for Tracking White Matter Integrity Changes in Myotonic Dystrophy Type 1 Patients using Deep Convolutional Neural Networks.
Kamali T; Day JW; Deutsch GK; Sampson JB; Murad A; Chaufty J; Parker D; Wozniak JR
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083393
[TBL] [Abstract][Full Text] [Related]
13. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
Weber YG; Roebling R; Kassubek J; Hoffmann S; Rosenbohm A; Wolf M; Steinbach P; Jurkat-Rott K; Walter H; Reske SN; Lehmann-Horn F; Mottaghy FM; Lerche H
Neurology; 2010 Apr; 74(14):1108-17. PubMed ID: 20220122
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2
Ates S; Deistung A; Schneider R; Prehn C; Lukas C; Reichenbach JR; Schneider-Gold C; Bellenberg B
Front Neurol; 2019; 10():1320. PubMed ID: 31920940
[TBL] [Abstract][Full Text] [Related]
16. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
[TBL] [Abstract][Full Text] [Related]
17. Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1.
Baldanzi S; Cecchi P; Fabbri S; Pesaresi I; Simoncini C; Angelini C; Bonuccelli U; Cosottini M; Siciliano G
Neuroimage Clin; 2016; 12():190-7. PubMed ID: 27437180
[TBL] [Abstract][Full Text] [Related]
18. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
19. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.
Minnerop M; Weber B; Schoene-Bake JC; Roeske S; Mirbach S; Anspach C; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Klockgether T; Kornblum C
Brain; 2011 Dec; 134(Pt 12):3530-46. PubMed ID: 22131273
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
